← stocks-llm Find companies like BSX →

Boston Scientific (BSX)

Health Care · Medical devices - Interventional and surgical solutions

A global medical-device innovator developing minimally invasive solutions for cardiovascular, rhythm management, and endoscopic procedures.

What Boston Scientific does

Boston Scientific Corporation develops, manufactures, and sells a broad portfolio of medical devices used in interventional and surgical procedures across cardiovascular disease, rhythm management, oncology, and endoscopy. The company generates net sales through its diverse product lines serving hospitals, ambulatory surgical centers, and physician offices globally. With operations across multiple geographic markets, BSX competes in highly specialized, regulated medical-device segments where innovation, clinical evidence, and reimbursement access drive customer adoption and market share.

Themes: ["Cardiovascular disease management","Minimally invasive procedures","Rhythm management and arrhythmia treatment","Endoscopic interventions","Medical device innovation","Global healthcare"]

Fundamentals

Dividend: does not currently pay a dividend.

Ask why BSX looks like this →

Key risks (from latest filing)

["Intense competition from larger competitors with greater resources and emerging low-cost alternatives may erode market share and pricing power","Regulatory delays or failures in obtaining product approvals and reimbursement coverage could impact product launches and revenue","Healthcare consolidation and government cost-control initiatives creating pricing pressure and reduced procedure volumes in key markets"]

See BSX's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.